William Bonello Neogenomics Inc (NEO) insider trading activity

William Bonello is Chief Financial Officer of NEOGENOMICS INC. Currently has a direct ownership of 191,548 shares of NEO, which is worth approximately $2.6 Million. The most recent transaction as insider was on Apr 28, 2022, when has been sold 5,727 shares (Common Stock) at a price of $7.52 per share, resulting in proceeds of $43,067. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 192K

0% 3M change

0% 12M change

Total Value Held $2.6 Million

William Bonello Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 28 2022	BUY Exercise of conversion of derivative security	$43,067 $7.52 p/Share	5,727 Added 2.9%	191,548 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	82,305 Added 30.7%	185,821 Common Stock
Mar 08 2022	BUY Exercise of conversion of derivative security	$37,600 $7.52 p/Share	5,000 Added 4.61%	103,516 Common Stock
Mar 07 2022	SELL Open market or private sale	$58,693 $18.29 p/Share	3,209 Reduced 3.15%	98,516 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	-	620 Reduced 0.61%	101,725 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	-	397 Reduced 0.39%	102,345 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	40,869 Added 28.46%	102,742 Common Stock
Dec 30 2021	BUY Grant, award, or other acquisition	-	21,400 Added 25.7%	61,873 Common Stock
Nov 30 2021	BUY Exercise of conversion of derivative security	$188,000 $7.52 p/Share	25,000 Added 38.18%	40,473 Common Stock
Nov 24 2021	SELL Open market or private sale	$928,250 $37.13 p/Share	25,000 Reduced 61.77%	15,473 Common Stock
Nov 24 2021	BUY Exercise of conversion of derivative security	$200,750 $8.03 p/Share	25,000 Added 38.18%	40,473 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	-	432 Reduced 3.74%	11,128 Common Stock
Mar 02 2021	BUY Grant, award, or other acquisition	-	4,345 Added 21.92%	15,473 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	-	500 Reduced 4.15%	11,560 Common Stock
Dec 02 2020	SELL Open market or private sale	$374,400 $46.8 p/Share	8,000 Reduced 39.88%	12,060 Common Stock
Dec 02 2020	BUY Exercise of conversion of derivative security	$64,240 $8.03 p/Share	8,000 Added 28.51%	20,060 Common Stock

William Bonello

Chief Financial Officer

Fort Myers, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEO shares.

Notify only if

Value

Insider Trading

Get notified when an Neogenomics Inc insider buys or sells NEO shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEOGENOMICS INC

Track Activities on NEO

Account